Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells
Sv. Lutsenko et al., Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells, BIOCHEM-MOS, 65(11), 2000, pp. 1299-1304
Cytotoxic activities, accumulation levels and dynamics, and intracellular d
istribution of the anthracycline antibiotics doxorubicin (DR) and carminomy
cin (CM) in the free forms or within conjugates with the epidermal growth f
actor (EGF) were for the first time compared in human breast carcinoma cell
lines MCF-7(Wt) and MCF-7(AdrR). The cytotoxic activities of DR and CM con
jugates with EGF were higher than the cytotoxic activities of the free anti
biotics in both cell lines. The accumulation levels of the free anthracycli
nes in both cell hues were lower than those of the conjugates and significa
ntly depended on the cell sensitivities to the antibiotics. On receptor-med
iated endocytosis of the anthracycline-EGF conjugates, the accumulation lev
els did not significantly depend on the cell sensitivities to the antibioti
cs. Both DR and CM, either free or conjugated with EGF, were mainly accumul
ated in nuclei. The free drugs were accumulated more rapidly, and the accum
ulation rates of both free and EGF-conjugated CM were higher than those of
DR preparations. The intracellular distribution of the free antibiotics sig
nificantly depended on the cell sensitivities to the anthracyclines, wherea
s the cell sensitivities had no effect on the distribution of the conjugate
s between the nucleus and cytoplasm. The rate of intracellular degradation
of DR and CM delivered to target cells within conjugates with EGF was twice
lower than that of the free antibiotics. The difference in the accumulatio
n levels and dynamics and in the intracellular distribution of the free and
conjugated DR and CM is likely to underlie the higher cytotoxic activities
of the anthracycline conjugates with EGF compared to the free drugs.